Uridine therapy for patients with elevated purine levels
US6727231B1 · kind B1 · utility
9Cited by
4References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2000 |
| Grant date | Apr 27, 2004 |
| Priority date | — |
| Expiry date | Oct 18, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is based on the discovery that patients having elevated purine levels, e.g., individuals diagnosed with pervasive developmental disorders, such as autistic disorder, and/or neuromuscular disorders, can be treated with uridine compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.